Although development of a jab for the H5N1 strain of avian flu is well under way, other strains are receiving less attention ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...
Although the COVID pandemic led to a better understanding of the coronaviruses, viruses, and vaccines, a backlash emerged to ...
A virus-like particle vaccine candidate for Crimean-Congo haemorrhagic fever has shown experimental rapid onset and durable ...
Despite the importance of GoF modifications, they have sometimes faced misplaced concerns or opposition that could lead to their being overregulated or even banned.
What did we learn during the pandemic and how do we prepare for the next one? That was the theme when representatives from academia, healthcare, authorities, politics and media met during two ...
In a recent essay, Jay Bhattacharya, director of the National Institutes of Health, laid out a strikingly different vision for how the United States should prepare for the next pandemic: do almost ...
In the event of a sudden pandemic, what should we do? This month, Jay Bhattacharya, the director of the National Institutes of Health, offered a remarkably blunt answer: nothing. It’s been nearly six ...
Listen to more stories on the Noa app. Last week, the two top officials at the National Institutes of Health—the world’s largest public funder of biomedical research—debuted a new plan to help ...
“The world needs a new pandemic playbook,” headlined City Journal on Nov. 13, because “the old one failed to cope with Covid and may even have caused it.” The author is Dr. Jay Bhattacharya, director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback